A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus

NCT00482989 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

183

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus

Interventions

BIOLOGICAL: MEDI 545
OTHER: Placebo

Sponsor

MedImmune LLC